These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 9025742

  • 41. Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
    Sesti A, Mayerhoefer M, Weber M, Anner P, Wadsak W, Dudczak R, Haug A, Karanikas G.
    Anticancer Res; 2014 Nov; 34(11):6647-54. PubMed ID: 25368270
    [Abstract] [Full Text] [Related]

  • 42. Role of Tc-99m DMSA (V) scanning and serum calcitonin monitoring in the management of medullary thyroid carcinoma.
    Howe TC, Padhy AK, Loke K, Magsombol B, Ng D, Goh A.
    Singapore Med J; 2008 Jan; 49(1):19-22. PubMed ID: 18204763
    [Abstract] [Full Text] [Related]

  • 43. The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer.
    Brandt-Mainz K, Müller SP, Görges R, Saller B, Bockisch A.
    Eur J Nucl Med; 2000 May; 27(5):490-6. PubMed ID: 10853802
    [Abstract] [Full Text] [Related]

  • 44. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.
    Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, Jager PL, Links TP.
    J Nucl Med; 2008 Apr; 49(4):524-31. PubMed ID: 18375923
    [Abstract] [Full Text] [Related]

  • 45. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
    Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, Lange H, Bredow J, Körber C, Grünwald F.
    Eur J Nucl Med; 2001 Nov; 28(11):1671-6. PubMed ID: 11702109
    [Abstract] [Full Text] [Related]

  • 46. Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
    Beuthien-Baumann B, Strumpf A, Zessin J, Bredow J, Kotzerke J.
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1604-9. PubMed ID: 17435996
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J, Dragan C, Schumm-Draeger PM, Usadel KH, Kusterer K.
    Br J Cancer; 2001 Nov 16; 85(10):1546-50. PubMed ID: 11720443
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.
    Dörr U, Sautter-Bihl ML, Bihl H.
    Semin Oncol; 1994 Oct 16; 21(5 Suppl 13):42-5. PubMed ID: 7992080
    [No Abstract] [Full Text] [Related]

  • 55. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S.
    J Clin Endocrinol Metab; 2007 Feb 16; 92(2):450-5. PubMed ID: 17119000
    [Abstract] [Full Text] [Related]

  • 56. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I.
    J Nucl Med; 1997 Mar 16; 38(3):348-52. PubMed ID: 9074515
    [Abstract] [Full Text] [Related]

  • 57. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning.
    Wei JP, Burke GJ.
    Ann Surg Oncol; 1995 May 16; 2(3):233-7. PubMed ID: 7641020
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
    Rufini V, Salvatori M, Saletnich I, Valenza V, Maussier ML, Martino G, Corsello SM, Pantusa M, Casolo A, Troncone L.
    Q J Nucl Med; 1995 Dec 16; 39(4 Suppl 1):140-4. PubMed ID: 9002774
    [Abstract] [Full Text] [Related]

  • 60. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A.
    J Clin Endocrinol Metab; 1994 Apr 16; 78(4):826-9. PubMed ID: 8157706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.